单孔胸腔镜彻底清创术治疗结核性脓胸合并胸壁结核
回顾性分析38例结核性脓胸合并胸壁结核患者接受单孔胸腔镜彻底清创术的资料,手术时间2.0(1.5)h,术后延长漏气发生率81.6%(31/38),随访25(11)个月所有患者切口一期愈合且结核无复发,结论认为该术式安全可行。
要点
- 38例结核性脓胸合并胸壁结核患者行单孔胸腔镜彻底清创术,术后延长漏气发生率81.6%(31/38)。
- 术后胸腔引流时间14(12)d,SB管引流时间21(14)d,随访25(11)个月结核无复发。
- 作者认为该术式联合术后规范抗结核治疗安全可行,远期恢复效果良好。
核心结论
- 单孔胸腔镜彻底清创术联合术后规范抗结核治疗用于结核性脓胸合并胸壁结核安全可行,可达到良好的远期恢复效果。
研究设计与样本
- 回顾性分析2019年3月至2021年8月在同济大学附属上海市肺科医院胸外科接受单孔胸腔镜彻底清创术治疗脓胸合并胸壁结核的38例患者资料,男性23例、女性15例,年龄30(25)岁(范围:18~78岁)。
- 所有患者全身麻醉下清理胸壁结核后经肋间窦道扩大成单孔切口,行全纤维板剥脱术,胸膜腔置胸腔引流管、胸壁结核处置SB管负压引流,不采用肌瓣填充及加压包扎。
- 无漏气时先拔除胸腔引流管,2~7 d后复查CT无明显残腔则拔除SB管后继续抗结核治疗,门诊及电话随访至2022年10月。
主要发现
- 手术时间2.0(1.5)h(范围:1~5 h),术中出血量100(175)ml(范围:100~1 200 ml)。
- 术后最常见并发症为延长漏气,发生率为81.6%(31/38)。
- 术后胸腔引流时间14(12)d(范围:2~31 d),术后SB管引流时间21(14)d(范围:4~40 d)。
- 随访时间25(11)个月(范围:13~42个月),所有患者切口均一期愈合,随访期间结核无复发。
临床怎么用
- 作者认为,单孔胸腔镜彻底清创术联合术后规范抗结核治疗可用于结核性脓胸合并胸壁结核,安全可行且远期恢复效果良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To examine the feasibility and technical considerations of thorough debridement using uniportal thoracoscopic surgery for tuberculous empyema complicated by chest wall tuberculosis. Methods: A retrospective analysis was conducted on 38 patients who underwent comprehensive uniportal thoracoscopy debridement for empyema complicated by chest wall tuberculosis in the Department of Thoracic Surgery, Shanghai Pulmonary Hospital, from March 2019 to August 2021. There were 23 males and 15 females, aged (M(IQR)) 30 (25) years (range: 18 to 78 years). The patients were cleared of chest wall tuberculosis under general anesthesia and underwent an incision through the intercostal sinus, followed by the whole fiberboard decortication method. Chest tube drainage was used for pleural cavity disease and negative pressure drainage for chest wall tuberculosis with SB tube, and without muscle flap filling and pressure bandaging. If there was no air leakage, the chest tube was removed first, followed by the removal of the SB tube after 2 to 7 days if there was no obvious residual cavity on the CT scan. The patients were followed up in outpatient clinics and by telephone until October 2022. Results: The operation time was 2.0 (1.5) h (range: 1 to 5 h), and blood loss during the operation was 100 (175) ml (range: 100 to 1 200 ml). The most common postoperative complication was prolonged air leak, with an incidence rate of 81.6% (31/38). The postoperative drainage time of the chest tube was 14 (12) days (range: 2 to 31 days) and the postoperative drainage time of the SB tube was 21 (14) days (range: 4 to 40 days). The follow-up time was 25 (11) months (range: 13 to 42 months). All patients had primary healing of their incisions and there was no tuberculosis recurrence during the follow-up period. Conclusion: Uniportal thoracoscopic thorough debridement combined with postoperative standardized antituberculosis treatment is safe and feasible for the treatment of tuberculous empyema with chest wall tuberculosis, which could achieve a good long-term recovery effect. 目的: 探讨利用单孔胸腔镜彻底清创术治疗结核性脓胸合并胸壁结核的可行性和技术要点。 方法: 回顾性分析2019年3月至2021年8月38例在同济大学附属上海市肺科医院胸外科接受单孔胸腔镜彻底清创术治疗脓胸合并胸壁结核患者的资料。男性23例,女性15例,年龄[M(IQR)]30(25)岁(范围:18~78岁)。所有患者全身麻醉下清理胸壁结核后经由肋间窦道扩大成单孔切口,以单孔脓胸纤维板剥脱的方法进行全纤维板剥脱术,胸膜腔内置入胸腔引流管引流,胸壁结核处置入SB管负压引流,不采用肌瓣填充及加压包扎。无漏气时先拔除胸腔引流管,2~7 d后复查CT无明显残腔则拔除SB管后继续抗结核治疗。门诊及电话随访至2022年10月。 结果: 手术时间2.0(1.5)h(范围:1~5 h),术中出血量100(175)ml(范围:100~1 200 ml),术后最常见并发症为延长漏气,发生率为81.6%(31/38)。术后胸腔引流时间14(12)d(范围:2~31 d),术后SB管引流时间21(14)d(范围:4~40 d)。随访时间为25(11)个月(范围:13~42个月),所有患者切口均一期愈合,随访期间结核无复发。 结论: 单孔胸腔镜彻底清创术治疗结核性脓胸合并胸壁结核是安全可行的,结合术后规范的抗结核治疗,远期恢复效果良好。.
引用
- Cai HM, Mao R, Deng Y, et al. [Uniportal thoracoscopic thorough debridement for tubercular empyema with abscess of the chest wall]. Zhonghua Wai Ke Za Zhi. 2023. PMID: 37400212. doi:10.3760/cma.j.cn112139-20221002-00417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。